Moreover, RNA sequencing of cells with loss-of-function mutations in TET2 showed augmented expression of pro-inflammatory mediators implicated in the pathogenesis of atherosclerosis including IL-1β and IL-6 [15]. This evidence concerns the gene IL1B and atherosclerosis.